A coronavirus vaccine built to stay useful even as viruses change has cleared its first test in people, offering an early ...
HealthDay on MSN
FDA approves Xocova for COVID-19 postexposure prophylaxis
The U.S. Food and Drug Administration has approved Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP ...
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to ...
1y
Covid-19
Get the latest news stories and videos on the Coronavirus with trackers on vaccines, hospitalizations, and deaths.
Wastewater signals show BA.3.2 across 25 states, while NWSS funding reductions threaten program continuity after FY2025, diminishing national situational awareness for emerging variants. Genomic ...
A common response between two types of immune cells during a COVID-19 infection and after initial vaccinations can cause ...
With the daily number of coronavirus cases in the United States still hovering at about 50,000 and American deaths from the disease approaching 160,000, cities across the country are taking ...
The new coronavirus variant surging in China has arrived in the US. Here’s what to know about Nimbus
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. A new coronavirus variant is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results